Literature DB >> 12437657

Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia.

Jörg Hessling1, Nicolaus Kröger, Mathias Werner, Tatjana Zabelina, Arne Hansen, Uwe Kordes, Francis Ayuketang Ayuk, Helmut Renges, Jörg Panse, Rudolf Erttmann, Axel Rolf Zander.   

Abstract

Three patients with myelofibrosis received allogeneic stem cell transplantation after a dose-reduced conditioning regimen of busulphan (8 mg/kg), fludarabine (180 mg/m2) and antithymocyte globulin (4 x 10 mg/kg). The median age at transplantation was 51 years (range 44-58). All patients engrafted with a leucocyte count > 1.0 x 10(9)/l after a median of 18 d (range 16-20). Grade II acute skin graft-versus-host disease (GvHD) occurred in one patient. One limited and one extensive chronic GvHD was observed. All patients achieved complete haematological remission. In one patient the fibrosis resolved completely 180 d post transplant. All patients are alive 126, 466 and 764 d after transplantation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12437657     DOI: 10.1046/j.1365-2141.2002.03884.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

Review 1.  Allogeneic hematopoietic cell transplantation in myelofibrosis with myeloid metaplasia.

Authors:  William J Hogan; Mark R Litzow; Ayalew Tefferi
Journal:  Curr Hematol Malig Rep       Date:  2007-02       Impact factor: 3.952

Review 2.  Reduced-intensity conditioning followed by allogeneic hematopoietic stem cell transplantation in myelofibrosis.

Authors:  Haefaa Alchalby; Nicolaus Kröger
Journal:  Curr Hematol Malig Rep       Date:  2010-04       Impact factor: 3.952

3.  Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of age.

Authors:  Scott Samuelson; Brenda M Sandmaier; Helen E Heslop; Uday Popat; George Carrum; Richard E Champlin; Rainer Storb; Josef T Prchal; Theodore A Gooley; H Joachim Deeg
Journal:  Br J Haematol       Date:  2011-02-17       Impact factor: 6.998

Review 4.  Current Challenges in Stem Cell Transplantation in Myelofibrosis.

Authors:  Nicolaus Kröger
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

Review 5.  Allogeneic hematopoietic cell transplantation for patients with myelofibrosis.

Authors:  Dae Young Zang; H Joachim Deeg
Journal:  Curr Opin Hematol       Date:  2009-03       Impact factor: 3.284

6.  Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: an analysis of the JSHCT.

Authors:  M Murata; T Nishida; S Taniguchi; K Ohashi; H Ogawa; T Fukuda; T Mori; H Kobayashi; C Nakaseko; N Yamagata; Y Morishima; T Nagamura-Inoue; H Sakamaki; Y Atsuta; R Suzuki; T Naoe
Journal:  Bone Marrow Transplant       Date:  2013-11-25       Impact factor: 5.483

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.